A phase II/III randomised trial comparing Epirubicin, Cisplatin and Protracted Venous Infusion (PVI) 5-Fluorouracil (5-FU) (ECF), Epirubicin, Oxaliplatin and PVI 5-FU (EOF), Epirubicin, Cisplatin and Capecitabine (ECX) and Epirubicin, Oxaliplatin and Capecitabine (EOX) in Patients with Advanced Oesophago-Gastric Cancer

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2002
This article has no abstract
Epistemonikos ID: 27565ab4ee1880868f13c18917f5d76b66aed1ad
First added on: Jan 17, 2025